225 related articles for article (PubMed ID: 23443091)
1. RORα, a potential tumor suppressor and therapeutic target of breast cancer.
Du J; Xu R
Int J Mol Sci; 2012 Nov; 13(12):15755-66. PubMed ID: 23443091
[TBL] [Abstract][Full Text] [Related]
2. RORα suppresses breast tumor invasion by inducing SEMA3F expression.
Xiong G; Wang C; Evers BM; Zhou BP; Xu R
Cancer Res; 2012 Apr; 72(7):1728-39. PubMed ID: 22350413
[TBL] [Abstract][Full Text] [Related]
3. Nuclear receptor retinoid-related orphan receptor alpha promotes apoptosis but is reduced in human gastric cancer.
Wang Z; Xiong F; Wang X; Qi Y; Yu H; Zhu Y; Zhu H
Oncotarget; 2017 Feb; 8(7):11105-11113. PubMed ID: 28052040
[TBL] [Abstract][Full Text] [Related]
4. Retinoid orphan nuclear receptor alpha (RORα) suppresses the epithelial-mesenchymal transition (EMT) by directly repressing Snail transcription.
Xiong G; Xu R
J Biol Chem; 2022 Jul; 298(7):102059. PubMed ID: 35605663
[TBL] [Abstract][Full Text] [Related]
5. RORα Suppresses Cancer-Associated Inflammation by Repressing Respiratory Complex I-Dependent ROS Generation.
Mao W; Xiong G; Wu Y; Wang C; St Clair D; Li JD; Xu R
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639006
[TBL] [Abstract][Full Text] [Related]
6. RORα binds to E2F1 to inhibit cell proliferation and regulate mammary gland branching morphogenesis.
Xiong G; Xu R
Mol Cell Biol; 2014 Aug; 34(16):3066-75. PubMed ID: 24891616
[TBL] [Abstract][Full Text] [Related]
7. The orphan nuclear receptor RORα is a potential endogenous protector in renal ischemia/reperfusion injury.
Cai J; Jiao X; Fang Y; Yu X; Ding X
FASEB J; 2019 Apr; 33(4):5704-5715. PubMed ID: 30673513
[TBL] [Abstract][Full Text] [Related]
8. The ROR nuclear orphan receptor subfamily: critical regulators of multiple biological processes.
Jetten AM; Kurebayashi S; Ueda E
Prog Nucleic Acid Res Mol Biol; 2001; 69():205-47. PubMed ID: 11550795
[TBL] [Abstract][Full Text] [Related]
9. RORα and RORγ expression inversely correlates with human melanoma progression.
Brożyna AA; Jóźwicki W; Skobowiat C; Jetten A; Slominski AT
Oncotarget; 2016 Sep; 7(39):63261-63282. PubMed ID: 27542227
[TBL] [Abstract][Full Text] [Related]
10. Identification of SR1078, a synthetic agonist for the orphan nuclear receptors RORα and RORγ.
Wang Y; Kumar N; Nuhant P; Cameron MD; Istrate MA; Roush WR; Griffin PR; Burris TP
ACS Chem Biol; 2010 Nov; 5(11):1029-34. PubMed ID: 20735016
[TBL] [Abstract][Full Text] [Related]
11. RORα2 requires LSD1 to enhance tumor progression in breast cancer.
Kim K; Lee JM; Yu YS; Kim H; Nam HJ; Moon HG; Noh DY; Kim KI; Fang S; Baek SH
Sci Rep; 2017 Sep; 7(1):11994. PubMed ID: 28931919
[TBL] [Abstract][Full Text] [Related]
12. The hidden switches underlying RORα-mediated circuits that critically regulate uncontrolled cell proliferation.
Shin D; Kim IS; Lee JM; Shin SY; Lee JH; Baek SH; Cho KH
J Mol Cell Biol; 2014 Aug; 6(4):338-48. PubMed ID: 24831657
[TBL] [Abstract][Full Text] [Related]
13. Modulation of retinoic acid receptor-related orphan receptor alpha and gamma activity by 7-oxygenated sterol ligands.
Wang Y; Kumar N; Solt LA; Richardson TI; Helvering LM; Crumbley C; Garcia-Ordonez RD; Stayrook KR; Zhang X; Novick S; Chalmers MJ; Griffin PR; Burris TP
J Biol Chem; 2010 Feb; 285(7):5013-25. PubMed ID: 19965867
[TBL] [Abstract][Full Text] [Related]
14. Retinoic Acid receptor-related orphan receptor alpha-enhanced thyroid hormone receptor-mediated transcription requires its ligand binding domain which is not, by itself, sufficient: possible direct interaction of two receptors.
Qiu CH; Miyazaki W; Iwasaki T; Londoño M; Ibhazehiebo K; Shimokawa N; Koibuchi N
Thyroid; 2009 Aug; 19(8):893-8. PubMed ID: 19645616
[TBL] [Abstract][Full Text] [Related]
15. DNA damage-induced RORα is crucial for p53 stabilization and increased apoptosis.
Kim H; Lee JM; Lee G; Bhin J; Oh SK; Kim K; Pyo KE; Lee JS; Yim HY; Kim KI; Hwang D; Chung J; Baek SH
Mol Cell; 2011 Dec; 44(5):797-810. PubMed ID: 22152482
[TBL] [Abstract][Full Text] [Related]
16. Novel Therapeutic Potential of Retinoid-Related Orphan Receptor α in Cardiovascular Diseases.
Chen Y; Zhang SP; Gong WW; Zheng YY; Shen JR; Liu X; Gu YH; Shi JH; Meng GL
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834872
[TBL] [Abstract][Full Text] [Related]
17. Lipid-sensors, enigmatic-orphan and orphan nuclear receptors as therapeutic targets in breast-cancer.
Garattini E; Bolis M; Gianni' M; Paroni G; Fratelli M; Terao M
Oncotarget; 2016 Jul; 7(27):42661-42682. PubMed ID: 26894976
[TBL] [Abstract][Full Text] [Related]
18. A second class of nuclear receptors for oxysterols: Regulation of RORalpha and RORgamma activity by 24S-hydroxycholesterol (cerebrosterol).
Wang Y; Kumar N; Crumbley C; Griffin PR; Burris TP
Biochim Biophys Acta; 2010 Aug; 1801(8):917-23. PubMed ID: 20211758
[TBL] [Abstract][Full Text] [Related]
19. Circadian clock components RORα and Bmal1 mediate the anti-proliferative effect of MLN4924 in osteosarcoma cells.
Zhang S; Zhang J; Deng Z; Liu H; Mao W; Jiang F; Xia Z; Li JD
Oncotarget; 2016 Oct; 7(40):66087-66099. PubMed ID: 27602774
[TBL] [Abstract][Full Text] [Related]
20. ROR alpha protects against LPS-induced inflammation by down-regulating SIRT1/NF-kappa B pathway.
Han S; Li Z; Han F; Jia Y; Qi L; Wu G; Cai W; Xu Y; Li C; Zhang W; Hu D
Arch Biochem Biophys; 2019 Jun; 668():1-8. PubMed ID: 31071300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]